BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT
Market News

Abbott Laboratories (ABT) Q4 2020 Earnings Call

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President and Chief Executive Officer Robert E. Funck — Executive Vice President, Finance and Chief Financial Officer Analysts: Bob Hopkins — Bank of America Merrill Lynch — Analyst Matthew Taylor — UBS — Analyst Robert Marcus — J.P. Morgan — […]

$ABT January 27, 2021 1 min read

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021.

Corporate Participants:

Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions

Robert B. Ford — President and Chief Executive Officer

Robert E. Funck — Executive Vice President, Finance and Chief Financial Officer

Analysts:

Bob Hopkins — Bank of America Merrill Lynch — Analyst

ADVERTISEMENT

Matthew Taylor — UBS — Analyst

Robert Marcus — J.P. Morgan — Analyst

David Lewis — Morgan Stanley — Analyst

Lawrence Biegelsen — Wells Fargo — Analyst

Joanne Wuensch — Citi — Analyst

ADVERTISEMENT

Vijay Kumar — Evercore ISI — Analyst

_________
To read the full earnings call transcript, click here

ADVERTISEMENT